These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22023934)

  • 1. Predictive QSAR modeling of phosphodiesterase 4 inhibitors.
    Kovalishyn V; Tanchuk V; Charochkina L; Semenuta I; Prokopenko V
    J Mol Graph Model; 2012 Feb; 32():32-8. PubMed ID: 22023934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
    Ventura C; Latino DA; Martins F
    Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactivities of a series of phosphodiesterase type 5 (PDE-5) inhibitors as modelled by MIA-QSAR.
    Antunes JE; Freitas MP; Rittner R
    Eur J Med Chem; 2008 Aug; 43(8):1632-8. PubMed ID: 18045743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TOMOCOMD-CARDD descriptors-based virtual screening of tyrosinase inhibitors: evaluation of different classification model combinations using bond-based linear indices.
    Casañola-Martín GM; Marrero-Ponce Y; Khan MT; Ather A; Sultan S; Torrens F; Rotondo R
    Bioorg Med Chem; 2007 Feb; 15(3):1483-503. PubMed ID: 17110117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR modeling of anti-invasive activity of organic compounds using structural descriptors.
    Katritzky AR; Kuanar M; Dobchev DA; Vanhoecke BW; Karelson M; Parmar VS; Stevens CV; Bracke ME
    Bioorg Med Chem; 2006 Oct; 14(20):6933-9. PubMed ID: 16908166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling studies of pyridopurinone derivatives--potential phosphodiesterase 5 inhibitors.
    Srivani P; Srinivas E; Raghu R; Sastry GN
    J Mol Graph Model; 2007 Jul; 26(1):378-90. PubMed ID: 17307372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR study of carboxylic acid derivatives as HIV-1 Integrase inhibitors.
    Cheng Z; Zhang Y; Fu W
    Eur J Med Chem; 2010 Sep; 45(9):3970-80. PubMed ID: 20561721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of QSAR/QSPR correlations using support vector machines, radial basis function neural networks, and multiple linear regression.
    Yao XJ; Panaye A; Doucet JP; Zhang RS; Chen HF; Liu MC; Hu ZD; Fan BT
    J Chem Inf Comput Sci; 2004; 44(4):1257-66. PubMed ID: 15272833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
    Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS; Roy K
    Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A neural networks-based drug discovery approach and its application for designing aldose reductase inhibitors.
    Hu L; Chen G; Chau RM
    J Mol Graph Model; 2006 Jan; 24(4):244-53. PubMed ID: 16226911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacophore modeling, 3D-QSAR and docking study of 2-phenylpyrimidine analogues as selective PDE4B inhibitors.
    Tripuraneni NS; Azam MA
    J Theor Biol; 2016 Apr; 394():117-126. PubMed ID: 26804643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling of p38 mitogen-activated protein kinase inhibitors using the Catalyst HypoGen and k-nearest neighbor QSAR methods.
    Xiao Z; Varma S; Xiao YD; Tropsha A
    J Mol Graph Model; 2004 Oct; 23(2):129-38. PubMed ID: 15363455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum.
    González-Díaz H; Prado-Prado F; Sobarzo-Sánchez E; Haddad M; Maurel Chevalley S; Valentin A; Quetin-Leclercq J; Dea-Ayuela MA; Teresa Gomez-Muños M; Munteanu CR; José Torres-Labandeira J; García-Mera X; Tapia RA; Ubeira FM
    J Theor Biol; 2011 May; 276(1):229-49. PubMed ID: 21277861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
    Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors.
    Tripuraneni NS; Azam MA
    J Biomol Struct Dyn; 2016 Nov; 34(11):2481-92. PubMed ID: 26587754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks.
    Nandi S; Vracko M; Bagchi MC
    Chem Biol Drug Des; 2007 Nov; 70(5):424-36. PubMed ID: 17949360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D-QSAR of novel phosphodiesterase-4 inhibitors by genetic function approximation.
    Raichurkar AV; Shah UA; Kulkarni VM
    Med Chem; 2011 Nov; 7(6):543-52. PubMed ID: 22313294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecule kernels: a descriptor- and alignment-free quantitative structure-activity relationship approach.
    Mohr JA; Jain BJ; Obermayer K
    J Chem Inf Model; 2008 Sep; 48(9):1868-81. PubMed ID: 18767832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.